Presence of human circulating progenitor cells for cancer stromal fibroblasts in the blood of lung cancer patients

Stem Cells

Volumn 25, Issue 6, 2007, Pages 1469-1477

  Ishii, Genichiro ^a   Ito, Ta Kashi ^a,b   Aoyagi, Kazuhiko ^c   Fujimoto, Hiroshi ^a   Chiba, Haruki ^a,b   Hasebe, Takahiro ^a   Fujii, Satoshi ^a   Nagai, Kanji ^a   Sasaki, Hiroki ^c   Ochiai, Atsushi ^a,b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cancer stromal fibroblast; Fibroblast progenitor cell; Lung cancer

Indexed keywords

CARBOXYFLUORESCEIN SUCCINYL ESTER; COLLAGEN TYPE 1; COMPLEMENTARY DNA; FLUORESCEIN DERIVATIVE; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MONONUCLEAR CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PULMONARY VEIN; SCID MOUSE; SPINDLE CELL; STATISTICAL SIGNIFICANCE; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA; CELL SEPARATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM TRANSPLANTATION; STEM CELLS; STROMAL CELLS;

ANIMALIA; MUS;

EID: 34547097767     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0449     Document Type: Article

References (40)

1. Schor SL, Schor AM. Clonal heterogeneity in fibroblast phenotype: Implications for the control of epithelial-mesenchymal interactions. Bioessays 1987;7:200-204.
2. Ronnov-Jessen L, Petersen OW, Koteliansky VE et al. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells J Clin Invest 1995;95:859-873.
3. Dugina V, Alexandrova A, Chaponnier C et al. Rat fibroblasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res 1998;238:481-490.
4. Koumas L, King AE, Critchley HO et al. Fibroblast heterogeneity: Existence of functionally distinct Thy 1(+) and Thy 1(-) human female reproductive tract fibroblasts. Am J Pathol 2001;159:925-935.
5. Postlethwaite AE, Shigemitsu H, Kanangat S. Cellular origins of fibroblasts: Possible implications for organ fibrosis in systemic sclerosis. Curr Opin Rheumatol 2004;16:733-738.
6. Brittan M, Hunt T, Jeffery R et al. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 2002;50:752-757.
7. Direkze NC, Forbes SJ, Brittan M et al. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. STEM CELLS 2003;21:514-520.
8. Hashimoto N, Jin H, Liu T et al. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
9. Ishii G, Sangai T, Oda T et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 2003;309:232-240.
10. Direkze NC, Hodivala-Dilke K, Jeffery R et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-8495.
11. Ishii G, Sangai T, Ito T et al. In vivo characterization bone marrow derived fibroblasts recruited into fibrotic lesions. Stem cells 2005;23:699-706.
12. Sangai T, Ishii G, Kodama K et al. Effect of differences in cancer cells and tumor growth sites on recruiting bone marrow-derived endothelial cells and myofibroblasts in cancer-induced stroma. Int J Cancer 2005;115:885-892.
13. Bucala R, Spiegel LA, Chesney J et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
14. Abe R, Donnelly SC, Peng T et al. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-7562.
15. Schmidt M, Sun G, Stacey MA et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171:380-389.
16. Eisen MB, Spellman PT, Brown PO et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-14868.
17. Suzuki K, Yokose T, Yoshida J et al. Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung. Ann Thorac Surg 2000;69:893-897.
18. World Health Organization. Histological Typing of Lung Tumors. 3rd ed. Geneva: World Health Organization, 1999.
19. Simper D, Stalboerger PG, Panetta CJ et al. Smooth muscle progenitor cells in human blood. Circulation 2002;106:1199-1204.
20. Deb A, Skelding KA, Wang S et al. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 2004;110:2673-2677.
21. Le Ricousse-Roussanne S, Barateau V, Contreres JO et al. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 2004;62:176-184.
22. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-977.
23. Asahara T, Masuda H, Takahashi T et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85:221-228.
24. Harraz M, Jiao C, Hanlon HD et al. CD34- blood-derived human endothelial cell progenitors. STEM CELLS 2001;19:304-312.
25. Phillips RJ, Burdick MD, Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-446.
26. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-242.
27. Zvaifler NJ, Marinova-Mutafchieva L, Adams G et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000;2:477-488.
28. Roufosse CA, Direkze NC, Otto WR et al. Circulating mesenchymal stem cells. Int. J Biochem Cell Biol 2004;36:585-597.
29. Kuwana M, Okazaki Y, Kodama H et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc. Biol 2003;74:833-845.
30. Hayflick L. The cell biology of human aging. N Engl J Med 1976;295:1302-1308.
31. Hayflick L. Recent advances in the cell biology of aging. Mech Ageing Dev 1980;14:59-79.
32. Campisi J. The biology of replicative senescence. Eur J Cancer 1997;33:703-709.
33. Lapis K, Timar J. Role of elastin-matrix interactions in tumor progression. Semin Cancer Biol 2002;12:209-217.
34. Duca L, Floquet N, Alix AJ et al. Elastin as a matrikine. Crit Rev Oncol Hematol 2004;49:235-244.
35. Ntayi C, Labrousse AL, Debret R et al. Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol 2004;122:256-265.
36. Wang C, Tammi M, Guo H et al. Hyaluronan distribution in the normal epithelium of esophagus, stomach, and colon and their cancers. Am J Pathol 1996;148:1861-1869.
37. Dai Y, Yang Y, MacLeod V et al. HSulf-1 and HSulf-2 are potent inhibitors of myeloma tumor growth in vivo. J Biol Chem 2005;280:40066-40073.
38. Kanomata N, Yokose T, Kamijo T et al. Hyaluronan synthase expression in pleural malignant mesotheliomas. Virchows Arch 2005;446:246-250.
39. Abedin M, Tintut Y, Demer LL. Mesenchymal stem cells and the artery wall. Circ Res 2004;95:671-676.
40. Covas DT, Piccinato CE, Orellana MD et al. Mesenchymal stem cells can be obtained from the human saphena vein. Exp Cell Res 2005;309:340-344.